Published in Proteomics Weekly, October 19th, 2009
"Inconsistent methodological approaches may have resulted in the underestimation of traditionally-defined PD in HIV+ individuals. To characterize the level, extent and predictors (i.e. immunologic, microbiologic, metabolic and behavioral) of PD in an HIV+ cohort during the era of highly active antiretroviral therapy (HAART). Cross-sectional study. HIV+ adults receiving...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.